Kenneth Coleman

Arietis

$7,183,423

Attributed

$7,183,423

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2M · FY2012–17

$2M$1.5M$1M$500K$0

'12

'13

'14

'15

'16

'17

Funding mix

By agency

NIH$7,183,423 · 3

By mechanism

R44$6,597,456 · 2

R43$585,967 · 1

Top collaborators

No co-investigators on record.

Most similar at Arietis

Same institution · by research overlap

Richard Edward Lee$36,742,506
Michael Lafleur$15,430,567

Others in their field

Top investigators on “Antimicrobial”

M Kariuki Njenga · Washington State University$56,426,595
Henry F Chambers · Duke University$39,750,596
Alon Singer · Helixbind, Inc.$37,820,504
Vance G Fowler · Duke University$37,779,645
Robert L Modlin · University Of California Los Angeles$35,877,010
Marian Ewell · The Emmes Company, Llc$35,864,978

Research focus

AntimicrobialAntibioticsIn VivoAntimicrobial ResistanceKillingsLeadPathogenInfectionFluoroquinolonesMouse ModelResistance DevelopmentToxic EffectDoseResistanceStaphylococcus AureusClinical TrialsBaseDrug ResistancePre-ClinicalFrequencies (Time Pattern)Antibiotic ResistanceDiarrheaBiological AvailabilityAdverse Effects